Evidence map›Paper›PMID 24462936›Full record

ReviewBrain research2014

Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders.

S M Francis, A Sagar, T Levin-Decanini, W Liu, C S Carter, S Jacob

Abstract readReview
In one paragraph

Review in Brain research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 1 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Trial
  3. Trial
  4. Lasting effects of early-life oxytocin treatment on LTP and episodic memory in a mouse model of Fragile X syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. AgRP neurons mediate activity-dependent development of oxytocin connectivity and autonomic regulation.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Disorders of puberty and neurodevelopment: A shared etiology?Annals of the New York Academy of Sciences · 2024
    Review
  11. Oxytocin and its links through scientific lineage.Comprehensive psychoneuroendocrinology · 2024
    Article
  12. Tales from the life and lab of a female social neuroscientist.Comprehensive psychoneuroendocrinology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Whole-Brain Wiring Diagram of Oxytocin System in Adult Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2022
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

S M FrancisUniversity of Minnesota, Department of Psychiatry, Minneapolis, MN, USA.
A SagarUniversity of California at Irvine, Department of Psychiatry and Human Behavior, USA.
T Levin-DecaniniUniversity of Minnesota, Department of Psychiatry, Minneapolis, MN, USA.
W LiuNorthwestern University, Feinberg School of Medicine, Chicago, IL, USA.
C S CarterUniversity of North Carolina, Department of Psychiatry, Chapel Hill, NC, USA.
S JacobUniversity of Minnesota, Department of Psychiatry, Minneapolis, MN, USA. Electronic address: sjacob@umn.edu.
University of Minnesota · USNorthwestern University · USUniversity of California, Irvine · USUniversity of North Carolina at Chapel Hill · US

Funding

Autism: neuropeptide hormones and potential pathway genesK23MH082121 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JACOB, SUMA · 2008 to 2012
$981k
NIMH NIH HHS K23 MH082121NIMH NIH HHS K23MH082121NIMH NIH HHS L40 MH072451
6 · The paper itself

Abstract

Oxytocin (OT) and arginine vasopressin (AVP) are two small, related neuropeptide hormones found in many mammalian species, including humans. Dysregulation of these neuropeptides have been associated with changes in behavior, especially social interactions. We review how the OT and AVP systems have been investigated in Autism Spectrum Disorder (ASD), Prader-Willi Syndrome (PWS), Williams Syndrome (WS) and Fragile X syndrome (FXS). All of these neurodevelopmental disorders (NDD) are marked by social deficits. While PWS, WS and FXS have identified genetic mutations, ASD stems from multiple genes with complex interactions. Animal models of NDD are invaluable for studying the role and relatedness of OT and AVP in the developing brain. We present data from a FXS mouse model affecting the fragile X mental retardation 1 (Fmr1) gene, resulting in decreased OT and AVP staining cells in some brain regions. Reviewing the research about OT and AVP in these NDD suggests that altered OT pathways may be downstream from different etiological factors and perturbations in development. This has implications for ongoing studies of the therapeutic application of OT in NDD. This article is part of a Special Issue entitled Oxytocin and Social Behav.

Indexed as

AnimalsBrainChild Development Disorders, PervasiveFragile X SyndromeHumansOxytocinPrader-Willi SyndromePsychotropic DrugsVasopressinsWilliams SyndromeOxytocinPsychotropic DrugsVasopressinsAutismFragile XOxytocinPrader–WilliVasopressinWilliams

Identifiers

PMID24462936
PMCPMC4305432
OpenAlexW1975206718

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.